16
Feb 2026
Healthcare systems worldwide are increasingly recognizing the importance of environmental sustainability, yet little is known about how healthcare professionals perceive and implement sustainable practices in Kazakhstan.
16
Feb 2026
How you take probiotics can affect their impact on the brain. A study from örebro University points to new possibilities for personalized approaches, depending on whether the primary aim is, for example, to improve memory or reduce depression.
16
Feb 2026
A recent study, published in Nature Communications, shows that in the Netherlands, people who are diagnosed with HIV are less likely to be employed, work fewer hours, earn less income, and are more likely to receive disability benefits up to seven years after diagnosis.
16
Feb 2026
A team led by LMU physician Sebastian Kobold has found a way to allow the body's immune system to destroy solid tumors.
_1b78fec41a5143afb6e7b9ad317023d2-620x480.jpg "Machine learning model demonstrates insulin resistance as a risk factor for 12 types of cancer")
16
Feb 2026
Insulin resistance - when the body doesn't properly respond to insulin, a hormone that helps control blood glucose levels - is one of the fundamental causes of diabetes.
16
Feb 2026
HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies.
16
Feb 2026
Spinal cord injury remains one of the most challenging neurological conditions to treat, largely because damage continues to worsen long after the initial trauma.
16
Feb 2026
Physical therapy is a key step on the path to recovery after injuries or certain surgical procedures. A new survey by The Ohio State University Wexner Medical Center shows 3 out of 4 (76%) patients don't complete their physical therapy homework, leading to stalled recoveries and potential surgical setbacks.
16
Feb 2026
In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are being utilized in CastleVax’s Phase II clinical trial for CVAX-01, an intranasal COVID-19 vaccine candidate.
16
Feb 2026
Secondary infections caused by bacteria or viruses during hospital care remain a long-standing global challenge, despite advances in modern medicine.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
